SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001593968-24-001096
Filing Date
2024-08-23
Accepted
2024-08-23 16:15:09
Documents
2
Period of Report
2024-08-21

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_01.html 4  
1 PRIMARY DOCUMENT primary_01.xml 4 4025
2 EX-24 DOCUMENT edouglaspoa.txt EX-24 3064
  Complete submission text file 0001593968-24-001096.txt   8545
Mailing Address BIOMIMETIC THERAPEUTICS, INC. 389 NICHOL MILL LANE FRANKLIN TN 37067
Business Address
Douglas Earl Martin (Reporting) CIK: 0001362155 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38693 | Film No.: 241236503

Mailing Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 457-2700
Allogene Therapeutics, Inc. (Issuer) CIK: 0001737287 (see all company filings)

IRS No.: 823562771 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)